Clinical perspective: Acromegaly and cancer: A problem

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 2935-2941

  Jenkins, P J ^a   Besser, M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADENOMATOUS POLYP; BREAST CARCINOMA; CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; GROWTH HORMONE BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 0034928043     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.7.7634     Document Type: Review

References (74)

1. Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?
2. Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly
3. Current treatment guidelines for acromegaly
4. Criteria for cure of acromegaly: A consensus statement
5. Modern approaches to treating acromegaly
6. Acromegaly and cancer
7. Increased incidence of neoplasia in patients with pituitary adenomas
8. Colon polyps in acromegaly
9. The prevalence and characteristics of colorectal neoplasia in acromegaly
10. Colorectal neoplasia in acromegaly
11. High prevalence of colonic polyps in patients with acromegaly. Influence of sex and age
12. The prevalence of colonic polyps in acromegaly: A colonoscopic and pathological study in 103 patients
13. Acromegaly, colonic polyps and carcinoma
14. Does acromegaly really predispose to an increased prevalence of gastrointestinal tumours?
15. Increased prevalence of colonic adenomas in patients with acromegaly
16. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones
17. Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly
18. Use of colonoscopy to screen asymptomatic adults for colorectal cancer
19. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings
20. Acromegaly is associated with colonomegaly which correlates with tissue exposure to growth hormone and may be implicated in their increased risk of colorectal neoplasia
21. Colon polyps prevalence in acromegalic patients
22. Colonic polyps in patients with acromegaly
23. Prevalence of colorectal carcinoma and polyps in acromegaly
24. Co-stimulation of gastro-intestinal tumour cell growth by gastrin, transforming growth factor α and insulin like growth factor-I
25. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor α
26. Hardonk et al. Increased epithelial cell proliferation in the colon of patients with acromegaly
27. The pathogenesis of colorectal neoplasia in acromegaly
28. Mortality and cancer incidence in acromegaly: A retrospective cohort study
29. IGF-I and the development of colorectal neoplasia in acromegaly
30. IGF-I and IGF-II in relation to colorectal cancer
31. Prospective study of colorectal cancer risk in men and plasma levels of insulin like growth factor (IGF)-1 and IGF-binding protein-3
32. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor α-induced mitogen-activated protein kinase and nuclear factor κB signaling pathways
33. Insulin and IGF-1 receptors signaling in protection from apoptosis
34. Expression of the apoptotic proteins BCL-2 and BAX in normal and neoplastic colonic epithelium from patients with and without acromegaly
35. Growth hormone stimulates sequential induction of c-myc and insulin-like growth factor I expression in vivo
36. Insulin-like growth factor I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells
37. Increased serum deoxycholic acid levels in men with colorectal adenomas
38. Unconjugated secondary bile acids in the serum of patients with colorectal adenomas
39. Increased serum deoxycholic acid levels in acromegalic patients with colorectal neoplasia
40. Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones
41. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas
42. Tight control of growth hormone: An attainable outcome for acromegaly treatment
43. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer
44. Acromegaly
45. Acromegaly and neoplasia
46. Benign and malignant tumors in patients with acromegaly
47. Ascertainment and natural history of treated acromegaly in Northern Ireland
48. Elevated growth hormone levels in sera from breast cancer patients
49. Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer
50. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
51. Neoplasms in rats treated with pituitary growth hormone. I. Pulmonary and lymphatic tissues
52. Hypophysectomy in treatment of disseminated breast cancer
53. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: Potential relevance to strategies for breast cancer treatment and prevention
54. Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells
55. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase
56. Growth hormone treatment induces mammary gland hyperplasia in aging primates
57. High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice
58. Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation
59. Prostatic hyperplasia: An unknown feature of acromegaly
60. Increased serum prostate specific antigen in acromegaly - A cross sectional study
61. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
62. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
63. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
64. Mortality in acromegaly
65. Epidemiology of acromegaly in the Newcastle region
66. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984
67. Acromegaly and gastrointestinal cancer
68. Increased incidence of neoplasia in females with acromegaly
69. Acromegaly and colon cancer
70. Colon cancer and polyps in acromegaly: Increased risk associated with family history of colon cancer
71. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: Influence of age, gender, and family history
72. Gastrointestinal tumors in acromegalic patients
73. Acromegaly and gastrointestinal adenocarcinomas
74. Benign and malignant tumors in patients with acromegaly